Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizia Suzzi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancers|September 28, 2021
Hepatic Cancer Stem Cells: Molecular Mechanisms, Therapeutic Implications, and Circulating BiomarkersLaura Gramantieri, Catia Giovannini, Fabrizia Suzzi, et al.
Biomolecules|January 8, 2025
Multifaceted Aspects of Dysfunctional Myelopoiesis in Cancer and Therapeutic Perspectives with Focus on HCCAndrea Arleo, Annapaola Montagner, Catia Giovannini, et al.
Biology|February 26, 2026
Overcoming Immunotherapy Resistance in Small-Cell Lung CancerMatteo Canale, Fabrizia Suzzi, Alberto Verlicchi, et al.
Biomolecules|January 8, 2025
Notch Signaling and PD-1/PD-L1 Interaction in Hepatocellular Carcinoma: Potentialities of Combined TherapiesAnnapaola Montagner, Andrea Arleo, Fabrizia Suzzi, et al.
Cancers|March 29, 2023
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab-Bevacizumab in Hepatocellular CarcinomaCatia Giovannini, Fabrizia Suzzi, Francesco Tovoli, et al.
Nutrients|April 23, 2022
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure AreaLaura Gramantieri, Federica Gnudi, Francesco Vasuri, et al.
European Journal of Immunology|November 22, 2023
Circulating CD8 lymphocytes predict response to atezolizumab-bevacizumab in hepatocellular carcinomaLaura Gramantieri, Fabrizia Suzzi, Cristian Bassi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancers|September 28, 2021
Hepatic Cancer Stem Cells: Molecular Mechanisms, Therapeutic Implications, and Circulating BiomarkersLaura Gramantieri, Catia Giovannini, Fabrizia Suzzi, et al.
Biomolecules|January 8, 2025
Multifaceted Aspects of Dysfunctional Myelopoiesis in Cancer and Therapeutic Perspectives with Focus on HCCAndrea Arleo, Annapaola Montagner, Catia Giovannini, et al.
Biology|February 26, 2026
Overcoming Immunotherapy Resistance in Small-Cell Lung CancerMatteo Canale, Fabrizia Suzzi, Alberto Verlicchi, et al.
Biomolecules|January 8, 2025
Notch Signaling and PD-1/PD-L1 Interaction in Hepatocellular Carcinoma: Potentialities of Combined TherapiesAnnapaola Montagner, Andrea Arleo, Fabrizia Suzzi, et al.
Cancers|March 29, 2023
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab-Bevacizumab in Hepatocellular CarcinomaCatia Giovannini, Fabrizia Suzzi, Francesco Tovoli, et al.
Nutrients|April 23, 2022
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure AreaLaura Gramantieri, Federica Gnudi, Francesco Vasuri, et al.
European Journal of Immunology|November 22, 2023
Circulating CD8 lymphocytes predict response to atezolizumab-bevacizumab in hepatocellular carcinomaLaura Gramantieri, Fabrizia Suzzi, Cristian Bassi, et al.
Pageof 1